10x Genomics, Inc. (TXG)

10x Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	644.47	610.79	618.73	516.41	490.49	298.85
Revenue Growth (YoY)	2.02%	-1.28%	19.81%	5.28%	64.13%	21.54%
Cost of Revenue	196.19	196	209.41	120.09	74.09	58.47
Gross Profit	448.28	414.78	409.31	396.32	416.4	240.38
Selling, General & Admin	337.97	343.24	343.33	295.8	257.56	202.33
Research & Development	254.71	264	265.73	264.27	211.75	123.38
Operating Expenses	592.68	607.24	609.06	560.07	469.31	325.7
Operating Income	-144.41	-192.46	-199.75	-163.74	-52.91	-85.32
Interest Expense	-0.01	-0	-0.03	-0.48	-0.87	-1.68
Interest & Investment Income	16.95	18.45	16.91	6.65	0.21	1.53
Currency Exchange Gain (Loss)	-2.1	-2.1	1.2	0.2	-0.9	1.3
Other Non Operating Income (Expenses)	6.35	0.52	0.21	-0.4	0.1	0.04
EBT Excluding Unusual Items	-123.2	-175.6	-181.47	-157.77	-54.38	-84.14
Merger & Restructuring Charges	-6.02	-	-	-4.2	-	-
Gain (Loss) on Sale of Investments	-0	-0	-1.72	-	-	-
Asset Writedown	-	-2.1	-4.6	-	-	-
Legal Settlements	49.9	-	-	-	0.66	-1.27
Other Unusual Items	-	-	-	-	-	-1.52
Pretax Income	-79.33	-177.7	-248.76	-161.97	-53.72	-534.48
Income Tax Expense	5.27	4.93	6.34	4.03	4.51	8.26
Net Income	-84.6	-182.63	-255.1	-166	-58.22	-542.73
Net Income to Common	-84.6	-182.63	-255.1	-166	-58.22	-542.73
Shares Outstanding (Basic)	122	120	117	114	110	101
Shares Outstanding (Diluted)	122	120	117	114	110	101
Shares Change (YoY)	2.95%	2.80%	2.90%	3.18%	9.09%	158.76%
EPS (Basic)	-0.69	-1.52	-2.18	-1.46	-0.53	-5.37
EPS (Diluted)	-0.69	-1.52	-2.18	-1.46	-0.53	-5.37
Free Cash Flow	56.88	-5.73	-63.8	-165.27	-122.65	-254.56
Free Cash Flow Per Share	0.47	-0.05	-0.55	-1.45	-1.11	-2.52
Gross Margin	69.56%	67.91%	66.15%	76.75%	84.89%	80.44%
Operating Margin	-22.41%	-31.51%	-32.28%	-31.71%	-10.79%	-28.55%
Profit Margin	-13.13%	-29.90%	-41.23%	-32.15%	-11.87%	-181.61%
Free Cash Flow Margin	8.82%	-0.94%	-10.31%	-32.00%	-25.01%	-85.18%
EBITDA	-110.85	-156.58	-164.24	-138.38	-31.8	-71.31
EBITDA Margin	-17.20%	-25.64%	-26.54%	-26.80%	-6.48%	-23.86%
D&A For EBITDA	33.55	35.88	35.51	25.37	21.12	14.01
EBIT	-144.41	-192.46	-199.75	-163.74	-52.91	-85.32
EBIT Margin	-22.41%	-31.51%	-32.28%	-31.71%	-10.79%	-28.55%
Advertising Expenses	-	3.9	3.3	3.7	4.7	1.9

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q